Astrazeneca PLC (02723534)
- Status
- active
- Formerly
- ZENECA GROUP PLC; HACKPLIMCO (NO. FIVE) PUBLIC LIMITED COMPANY; ICI BIOSCIENCE PLC; HACKPLIMCO (NO.FIVE) PUBLIC LIMITED COMPANY
- Incorporated
- 1992-06-17
- Registered office
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
- Industry
- 21100 Manufacture of basic pharmaceutical products; 21200 Manufacture of pharmaceutical preparations; 46460 Wholesale of pharmaceutical goods; 72110 Research and experimental development on biotechnology
Profit and loss
| Line item | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|
| Gross profit | 24,980,000,000 | 31,960,000,000 | 37,543,000,000 | – |
|---|
| Operating profit | 1,056,000,000 | 3,757,000,000 | 8,193,000,000 | – |
|---|
| Profit before tax | – | 2,501,000,000 | 6,899,000,000 | – |
|---|
| Tax charge / (credit) | -380,000,000 | -792,000,000 | -142,000,000 | – |
|---|
| Profit after tax | 115,000,000 | 3,293,000,000 | 7,041,000,000 | – |
|---|
Balance sheet
| Line item | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|
| Total fixed / non-current assets | 63,555,000,000 | 64,189,000,000 | 62,019,000,000 | 85,351,000,000 |
|---|
| Current assets | 2,612,000,000 | 10,932,000,000 | 5,815,000,000 | 28,723,000,000 |
|---|
| Cash at bank | – | – | 5,488,000,000 | – |
|---|
| Creditors < 1 year (current liabilities) | 3,125,000,000 | 3,211,000,000 | 2,199,000,000 | – |
|---|
| Net current assets | -513,000,000 | 7,721,000,000 | 3,616,000,000 | – |
|---|
| Creditors > 1 year (non-current liabilities) | 17,939,000,000 | 16,741,000,000 | 14,549,000,000 | 24,715,000,000 |
|---|
| Net assets | 45,080,000,000 | 55,148,000,000 | 40,871,000,000 | 48,719,000,000 |
|---|
| Total equity | 45,080,000,000 | 55,148,000,000 | 40,871,000,000 | 48,719,000,000 |
|---|
Cash flow
| Line item | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|
| Net cash from operating activities | – | 0 | 1,000,000 | – |
|---|
| Free cash flow | – | 0 | 1,000,000 | – |
|---|
Ratios
| Ratio | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|
| Return on equity | 0.3% | 6.6% | 14.7% | – |
|---|
| Return on capital employed | 1.7% | 5.2% | 12.5% | – |
|---|
| Return on invested capital (ROIC) | 1.9% | 5.6% | 13.6% | – |
|---|
| Current ratio | 0.84× | 3.40× | 2.64× | – |
|---|
| Effective tax rate | – | -31.7% | -2.1% | – |
|---|
Markdown version · CSV · Companies House register
